Mission
The Inflammatory Breast Cancer International Consortium (IBC-IC) is dedicated to worldwide collaborative research to foster advancements in the understanding and treatment of inflammatory breast cancer (IBC). The consortium was established to unite efforts among researchers and clinicians globally to improve screening, early detection, treatment options, and patient outcomes.
Basic Information
Tax-Exempt
Founded in
2013
EIN
46-3393042
Total Assets
$164.9 thousand
At a Glance
International Collaboration
The consortium fosters collaboration among international researchers and clinicians to advance understanding and treatment for IBC.
Ongoing Research and Trials
IBC-IC is involved in critical research and clinical trials to improve treatment outcomes for patients.
Community Impact
The IBC-IC creates a community of patients, researchers, and clinicians dedicated to improving lives affected by IBC.
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
51
44
/100
Program Expense Ratio
100.00%
20
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0
2
/20
Working Capital Ratio
6.203
18
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 8.455K | 100.00% |
| Program Services | 0 | 0.00% |
| Investment Income | 0 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 8.455K | 100.00% |
